Emergen Research has recently published its latest report titled “Metastatic Cancer Treatment Market By Treatment Type, By Application, By End-Use, Forecasts to 2027.”
Emergen Research has recently published its latest report titled “Metastatic Cancer Treatment Market By Treatment Type, By Application, By End-Use, Forecasts to 2027.”
According to the latest report by Emergen Research, the global metastatic cancer treatment market size was USD 63.03 Billion in 2019 and is expected to reach USD 111.16 Billion in 2027 and register a revenue CAGR of 7.3% during the forecast period, 2020-2027.
Market Dynamics:
Metastasis occurs when cancer progresses to different parts of the body from where it originated and it is the culmination of neoplastic progression. Cancer metastasis is a major challenge in cancer treatment as it is difficult to diagnose and treat. Metastasis accounts for 90% of cancer associated mortality and only a small number of patients with metastatic cancer can be treated with conventional strategies such as chemotherapy, radiotherapy and surgical removal.
Increasing focus on development of new strategies to prevent metastasis, rapid adoption of stem cells and oncolytic viruses to treat metastatic cancer, and growing caseload of cancer across the globe are some key factors expected to drive market revenue growth over the forecast period. In addition, increasing research and development activities to understand molecular mechanisms of metastasis and rising number of clinical trials to develop personalized treatments that can specifically target metastases are some other key factors expected to contribute revenue growth of the market going ahead.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/329
Metastasis is the major reason for treatment failure in cancer patients and accounts for majority of cancer-related deaths. Metastasis also causes treatment failure even in tumors that are sensitive to chemotherapy or radiotherapy. Metastatic tumors are difficult to treat with conventional therapy due to their anatomically diffuse localization and resistance to cytotoxic agents. Rapid technological advancements in imaging and cancer cell identification have significantly improved understanding of cancer metastasis. Treatment of metastatic cancer primarily aims to slow the growth or spread of cancer and typically requires systemic therapy or oral or intravenous medications to reach cancer cells throughout the body.
Other treatment approaches include immunotherapy, radiation therapy, surgical intervention, or a combination of these treatments. In addition, clinical trials offer access top novel treatment approaches that can prove to be more appropriate and effective as compared to standard of care options. Various therapeutic options are available to ease side effects and enhance quality of life of patients even after metastatic cancer has stopped responding to treatments. Development of new strategies to manage and treat metastatic cancer and advancements in stem cell therapy are some factors expected to drive market revenue growth over the forecast period.
However, difficulties associated with the treatment of metastatic cancer, high costs of cancer treatment, and resistance of metastatic cells to conventional treatment approaches and cytotoxic agents are some key factors expected to restrain market growth to a certain extent over the forecast period. In addition, lack of knowledge regarding metastatic processes, recurrence of cancer, and systemic side effects of treatment are some other factors expected to hamper market growth to a certain extent over the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Chemotherapy Segment to Account for Largest Revenue Share:
Chemotherapy segment is expected to account for largest revenue share over the forecast period attributable to increasing administration of chemotherapy as the primary treatment approach for metastatic cancer. Chemotherapy is prescribed alone or in conjunction with radiotherapy and surgery to slow progression of cancer, prevent multiplying of cancer cells, and to effectively kill metastatic cancer cells, among others.
Increasing Incidence of Breast Cancer Driving Revenue Growth of Metastatic Cancer Treatment Market:
Breast cancer segment is expected to dominate other application segment in terms of revenue share over the forecast period attributable to rapidly rising incidence of breast cancer across the globe, growing demand for advanced imaging and diagnosis techniques to detect metastatic breast cancer, and growing R&D activities to develop novel treatment approaches for metastatic breast cancer.
North America to Lead in Terms of Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period attributable to increasing prevalence of cancer in the region, availability of advanced treatments and therapeutic options, presence of established healthcare infrastructure, increasing number of initiatives to raise awareness regarding early diagnosis and detection of cancer, and robust presence of key market players in the region.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/329
Major Companies in the Market Include:
- Bayer AG
- Johnson & Johnson
- AstraZeneca PLC
- Pfizer Inc.
- Bristol Myers Squibb Company
- F. Hoffmann-La Roche AG
- Amgen Inc.
- Merck & Co. Inc.
- AbbVie Inc.
- Novartis AG
For the purpose of this report, Emergen Research has segmented the global metastatic cancer treatment market on the basis of treatment type, application, end-use, and region:
Treatment Type Outlook (Revenue, USD Billion; 2017-2027)
- Chemotherapy
- Hormone Therapy
- Immunotherapy
- Others
Application Outlook (Revenue, USD Billion; 2017-2027)
- Breast Cancer
- Lung Cancer
- Melanoma
- Prostate Cancer
- Colorectal Cancer
- Others
End Use Outlook (Revenue, USD Billion; 2017-2027)
- Hospital
- Clinics
- Research Institutes
- Others
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/metastatic-cancer-treatment-market
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Explore more reports offered by Emergen Research:
The global immunotherapy drugs market size was USD 154.40 Billion in 2019 and is expected to reach USD 365.57 Billion by 2027, at a CAGR of 12.1% during the forecast period. The global immunotherapy drugs market is anticipated to expand substantially in the near future, owing to the increasing cancer incidence across the globe.
The global healthcare supply chain management market size was SD 2.04 Billion in 2019 and is anticipated to reach USD 3.67 Billion by 2027, registering a CAGR of 7.6% during the forecast period. Focus of healthcare supply chain management (SCM) is to identify and reduce waste and help in supply chain decision making. It also contributes to the quality of the services offered. Advent of cloud-based solutions is boosting the market.
The global elder care services & assistive devices market size was USD 672.25 Billion in 2019 and is projected to reach USD 1,020.00 Billion by 2027, at a CAGR of 5.3% during the forecast period. Elderly care services and assistive devices are witnessing high demand, which can be attributed to factors such as growing elderly population, increasing adoption of technology amongst elders for health management, diversified requirements and preference of elders, and increased investments in R&D activities.
The global laboratory informatics market size was USD 2.37 Billion in 2019 and is expected to reach USD 3.87 Billion by 2027, at a CAGR of 6.8% during the forecast period. The global laboratory informatics market is expected to expand significantly in the next few years, due to increasing need for scientific data integration solutions and growing adoption of laboratory information management systems. Besides, emergence of cost-effective solutions for informatics is also anticipated to fuel the global laboratory informatics market during the forecast period.
Top 10 Leading and Most Promising Telepresence Robots Companies in the World
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-metastatic-cancer-treatment-market